These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15279125)

  • 21. Buprenorphine: effective treatment of opioid addiction starts in the office.
    Fiellin DA
    Am Fam Physician; 2006 May; 73(9):1513-4. PubMed ID: 16719242
    [No Abstract]   [Full Text] [Related]  

  • 22. Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
    Amass L; Ling W; Freese TE; Reiber C; Annon JJ; Cohen AJ; McCarty D; Reid MS; Brown LS; Clark C; Ziedonis DM; Krejci J; Stine S; Winhusen T; Brigham G; Babcock D; Muir JA; Buchan BJ; Horton T
    Am J Addict; 2004; 13 Suppl 1(Suppl 1):S42-66. PubMed ID: 15204675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lofexidine (Lucemyra) for opioid withdrawal.
    Med Lett Drugs Ther; 2018 Jul; 60(1551):115-117. PubMed ID: 30036346
    [No Abstract]   [Full Text] [Related]  

  • 25. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.
    Cisewski DH; Santos C; Koyfman A; Long B
    Am J Emerg Med; 2019 Jan; 37(1):143-150. PubMed ID: 30355476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies.
    Li X; Shorter D; Kosten TR
    Expert Opin Pharmacother; 2014 Oct; 15(15):2263-75. PubMed ID: 25171726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy for Substance Use Disorders.
    Klein JW
    Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine maintenance: a new treatment for opioid dependence.
    Collins GB; McAllister MS
    Cleve Clin J Med; 2007 Jul; 74(7):514-20. PubMed ID: 17682629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine: a primer for emergency physicians.
    Sporer KA
    Ann Emerg Med; 2004 May; 43(5):580-4. PubMed ID: 15111917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
    Sigmon SC; Bigelow GE
    Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
    Ling W; Wesson DR
    Drug Alcohol Depend; 2003 May; 70(2 Suppl):S49-57. PubMed ID: 12738350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid dependence treatment, including buprenorphine/naloxone.
    Raisch DW; Fye CL; Boardman KD; Sather MR
    Ann Pharmacother; 2002 Feb; 36(2):312-21. PubMed ID: 11847954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanded table: Some drugs for management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
    [No Abstract]   [Full Text] [Related]  

  • 34. A New Role for Clonidine in Addictions: Catching Relapses Before They Happen.
    deWit H
    Am J Psychiatry; 2015 Aug; 172(8):700-1. PubMed ID: 26234590
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug; 60(1554):137-141. PubMed ID: 30133420
    [No Abstract]   [Full Text] [Related]  

  • 36. Policy progress for physician treatment of opiate addiction.
    Merrill JO
    J Gen Intern Med; 2002 May; 17(5):361-8. PubMed ID: 12047733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment options for opiate addiction.
    J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
    [No Abstract]   [Full Text] [Related]  

  • 38. Helping 'them': our role in recovery from opioid dependence.
    Loxterkamp D
    Ann Fam Med; 2006; 4(2):168-71. PubMed ID: 16569721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detoxification and treating opioid dependence.
    de Jong CJ
    JAMA; 2006 Feb; 295(8):887; author reply 887-8. PubMed ID: 16493098
    [No Abstract]   [Full Text] [Related]  

  • 40. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.
    Arfken CL; Johanson CE; di Menza S; Schuster CR
    J Subst Abuse Treat; 2010 Sep; 39(2):96-104. PubMed ID: 20598829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.